Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric A Weaver

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Plos One|February 25, 2011
Real-time dynamic imaging of virus distribution in vivoSean E Hofherr, Kristen E Adams, Christopher Y Chen, et al.
Vaccines|November 28, 2019
Influenza H1 Mosaic Hemagglutinin Vaccine Induces Broad Immunity and Protection in MiceBrigette N Corder, Brianna L Bullard, Jennifer L DeBeauchamp, et al.
Nature Communications|February 23, 2021
Epigraph hemagglutinin vaccine induces broad cross-reactive immunity against swine H3 influenza virusBrianna L Bullard, Brigette N Corder, Jennifer DeBeauchamp, et al.
Msphere|August 1, 2024
Lipid nanoparticle-encapsulated DNA vaccine confers protection against swine and human-origin H1N1 influenza virusesThe N Nguyen, Danh C Lai, Sarah Sillman, et al.
NPJ Vaccines|June 23, 2022
An epitope-optimized human H3N2 influenza vaccine induces broadly protective immunity in mice and ferretsBrianna L Bullard, Jennifer DeBeauchamp, Matthew J Pekarek, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 21, 2011
Generation of a Kupffer cell-evading adenovirus for systemic and liver-directed gene transferReeti Khare, Shannon M May, Francesco Vetrini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2011
Species D adenoviruses as oncolytics against B-cell cancersChristopher Y Chen, Julien S Senac, Eric A Weaver, et al.
Journal of Virology|July 26, 2019
The Vaccinia Virus (VACV) B1 and Cellular VRK2 Kinases Promote VACV Replication Factory Formation through Phosphorylation-Dependent Inhibition of VACV B12Amber B Rico, Zhigang Wang, Annabel T Olson, et al.
Plos One|April 1, 2009
Comparison of replication-competent, first generation, and helper-dependent adenoviral vaccinesEric A Weaver, Pramod N Nehete, Stephanie S Buchl, et al.
Vaccines|May 7, 2025
Synthetic Neuraminidase Vaccine Induces Cross-Species and Multi-Subtype ProtectionMatthew J Pekarek, Erika M Petro-Turnquist, Nicholas E Jeanjaquet, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Plos One|February 25, 2011
Real-time dynamic imaging of virus distribution in vivoSean E Hofherr, Kristen E Adams, Christopher Y Chen, et al.
Vaccines|November 28, 2019
Influenza H1 Mosaic Hemagglutinin Vaccine Induces Broad Immunity and Protection in MiceBrigette N Corder, Brianna L Bullard, Jennifer L DeBeauchamp, et al.
Nature Communications|February 23, 2021
Epigraph hemagglutinin vaccine induces broad cross-reactive immunity against swine H3 influenza virusBrianna L Bullard, Brigette N Corder, Jennifer DeBeauchamp, et al.
Msphere|August 1, 2024
Lipid nanoparticle-encapsulated DNA vaccine confers protection against swine and human-origin H1N1 influenza virusesThe N Nguyen, Danh C Lai, Sarah Sillman, et al.
NPJ Vaccines|June 23, 2022
An epitope-optimized human H3N2 influenza vaccine induces broadly protective immunity in mice and ferretsBrianna L Bullard, Jennifer DeBeauchamp, Matthew J Pekarek, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 21, 2011
Generation of a Kupffer cell-evading adenovirus for systemic and liver-directed gene transferReeti Khare, Shannon M May, Francesco Vetrini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2011
Species D adenoviruses as oncolytics against B-cell cancersChristopher Y Chen, Julien S Senac, Eric A Weaver, et al.
Journal of Virology|July 26, 2019
The Vaccinia Virus (VACV) B1 and Cellular VRK2 Kinases Promote VACV Replication Factory Formation through Phosphorylation-Dependent Inhibition of VACV B12Amber B Rico, Zhigang Wang, Annabel T Olson, et al.
Plos One|April 1, 2009
Comparison of replication-competent, first generation, and helper-dependent adenoviral vaccinesEric A Weaver, Pramod N Nehete, Stephanie S Buchl, et al.
Vaccines|May 7, 2025
Synthetic Neuraminidase Vaccine Induces Cross-Species and Multi-Subtype ProtectionMatthew J Pekarek, Erika M Petro-Turnquist, Nicholas E Jeanjaquet, et al.
Pageof 7